Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Taiwan · Delayed Price · Currency is TWD

50.00

+1.20 (2.46%)

At close: Jul 9, 2026

-21.14% (1Y)

Market Cap	2.27B -23.9%
Revenue (ttm)	569.57M -4.3%
Net Income	98.23M +15.1%
EPS	2.14 +13.9%
Shares Out	45.46M
PE Ratio	23.34
Forward PE	n/a
Dividend	1.05 (2.15%)
Ex-Dividend Date	Jul 6, 2026

Volume	16,321
Open	51.30
Previous Close	48.80
Day's Range	50.00 - 51.30
52-Week Range	48.10 - 80.40
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1959

Employees 182

Stock Exchange Taipei Exchange

Ticker Symbol 4747

Full Company Profile

Financial Performance

In 2025, TPEX:4747's revenue was 569.77 million, a decrease of -6.81% compared to the previous year's 611.42 million. Earnings were 53.51 million, a decrease of -36.40%.

Financial Statements